In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, ...

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

Immuneering Corporation - Special CallCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO & DirectorConference Call ...

Increasing blood vitamin D levels with high-dose supplementation shows promise for people with first symptoms suggestive of ...

Trump’s assertions about autism have left scientists and doctors in despair. Katie Strick debunks each of his ‘outright lies’ ...

Tylenol is one of the most common pain relievers recommended to pregnant women, but the White House wants that to change over ...

In 1989, Sir Tim revolutionized the online world. Today, in the era of misinformation, addictive algorithms, and extractive ...